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ABSTRACT 
The present study was undertaken to investigate the hepatoprotective effect of pantothenic 
acid on CCl4-induced liver damage. Male Wistar rats were orally treated with pantothenic ac-
id (0.005, 0.01, 0.025, 0.05 and 0.1 g/kg) daily, with administration of CCl4 (1 mL/kg, 50 % 
CCl4 in olive oil) twice a week for 28 days. The effect of pantothenic acid on serum markers 
(alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and -glutamyl-
transferase) was measured in CCl4-induced hepatotoxicity in rat. Further, the effects on en-
zymatic antioxidant (superoxide dismutase) were estimated in the liver samples. CCl4 chal-
lenge not only elevated the serum marker enzyme activities but also suppressed hepatic anti-
oxidative defense system including superoxide dismutase. The biochemical observations were 
supplemented with histopathological examination of rat liver sections. Histopathological ex-
amination of livers showed that pantothenic acid reduced fatty degeneration, cytoplasmic 
vacuolization and necrosis in CCl4-treated rats. Therefore, pantothenic acid may be an effec-
tive hepatoprotective agent and viable candidate for treating hepatic disorders and other oxi-
dative stress-related diseases. 
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INTRODUCTION 
Pantothenic acid (also called vitamin 
B5), a member of the B-vitamin family, is 
an essential nutrient to all forms of life 
(Plesofsky-Vig, 1999). Its name originates 
from the Greek word pantothen (Pantoyen), 
meaning ‘‘from everywhere,’’ because 
small quantities of pantetheine are found in 
nearly every form of food, with high 
amounts in whole-grain cereals, legumes, 
eggs, and meat. Pantothenic acid was de-
scribed first as Lactobacillus bulgaricus 
growth factor (Williams et al., 1949). Pan-
tothenic acid is involved in a number of  
biological reactions, including the produc-
tion of energy, the catabolism of fatty acids 
and amino acids, the synthesis of fatty ac-
ids, phospholipids, sphingolipids, choles-
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terol, synthesis of amino acids such as leu-
cine, arginine and methionine, steroid hor-
mones, and the synthesis of heme and the 
neurotransmitter acetylcholine (Plesofsky-
Vig, 1996). Pantothenic acid is a compo-
nent of coenzyme A (CoA), an essential 
coenzyme in a variety of reactions that sus-
tain life. It is also involved in the synthesis 
of adrenal cortical hormones (Hurley and 
Morgan, 1952; Jaroenporn et al., 2008; 
Schultz et al., 1952a, b; Winters et al., 
1952) and growth of skin, hair and nerves 
(Fidanza, 1983; Kuo et al., 2007). On the 
other hand, the serum triglyceride and free 
fatty acid levels were significantly elevated 
in dietary pantothenic acid-deficient rats 
(Wittwer et al., 1990). Pantothenic acid was 
reported to protect cells and organs against 
peroxidative damage by increasing the con-
tent of cell glutathione (Slyshenkov et al., 
2004). 
The liver regulates several important 
functions including metabolism, and is an 
important organ for detoxification of hepa-
totoxicants which can cause hepatic injury 
during metabolic reaction. The pathogene-
sis of this damage involves all cell types in 
the liver via death and regeneration pro-
cesses and progress to chronic hepatitis, 
fibrosis, cirrhosis and hepatocellular carci-
noma (Giannelli et al., 2003). Oxidative 
stress has been regarded as a major contrib-
utor to the development of various hepatic 
disorders (Albano, 2008; Aram et al., 2009; 
Ferret et al., 2001; Nagata et al., 2007; Sa-
kurai et al., 2008). The reactive oxygen 
species (ROS) are known to play a major 
role in either the initiation or progression of 
carcinogenesis by inducing oxidative stress 
(Sun, 1990; Gulcin, 2006). Oxidative stress 
plays a crucial role in the development of 
carbon tetrachloride (CCl4) - induced hepa-
totoxicity (Sureshkumar and Mishra, 2006), 
and a connection between oxidative stress 
and lipid peroxidation has been reported 
(Kota et al., 2008). Numerous studies noted 
that CCl4 is widely used to induce liver 
damage because it is metabolized in 
hepatocytes by cytochrome P450, generating 
a highly reactive carbon-centered tri-
chloromethy radical, leading to initiating a 
chain of lipid peroxidation and thereby 
causing liver fibrosis (Fang et al., 2008; 
Weber et al., 2003). 
The aim of the present study was to ex-
amine the effects of pantothenic acid on 
CCl4-induced acute hepatic injury in rats. 
 
MATERIALS AND METHODS 
Chemicals 
Pantothenic acid was obtained from 
Sigma-Aldrich; St. Louis, MO. Carbon tet-
rachloride was purchased from Merck, 
Germany. The kits for alanine aminotrans-
ferase (ALT), aspartate aminotransferase 
(AST) and alkaline phosphatase (ALP) 
were purchased from Parsazmoon Compa-
ny of Iran. The kit for -glutamyltransferase 
(GGT) was obtained from Bionik of Italy. 
The kit for superoxide dismutase (SOD) 
was purchased from Randox Company of 
England. All the other chemicals and rea-
gents used were of analytical grade.  
 
Animals 
Adult male Wistar rats with body 
weights of 180-230 g were used in the 
study. The animals were maintained under 
standard environmental conditions (23-
25 °C, 12 h/12 h light/dark cycle) and had 
free access to standard rodent pellet diet 
and water ad libitum. The animals were ac-
climatized in the laboratory conditions for a 
week before the commencement of the 
study. The experimental procedures adopt-
ed in this study were in strict compliance 
with the United States National Institutes of 
Health Guidelines for Care and Use of La-
boratory Animals in Biomedical Research 
(1985, no. 85-23). 
 
Experimental design 
The method of Habbu et al. (2008) was 
used in this study. Rats were divided into 9 
groups of 9 animals each. Treatment was 
then carried out according to the group al-
lotment below: 
 Group I received olive oil and saline 
served as vehicle control animals. 
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 Groups II-III were administrated panto-
thenic acid dissolved in distilled water 
daily using an intragastric tube (ga-
vage) at dose levels of 0.01 and 0.025g/ 
kg b.w., respectively. 
 Group IV was the hepatotoxicity group 
that was given carbon tetrachloride 
(i.p., 0.5 mL/kg b.w., 50 % CCl4 in ol-
ive oil) twice a week. 
 Groups V-IX were administrated pan-
tothenic acid dissolved in distilled wa-
ter daily using an intragastric tube (ga-
vage) at dose levels of 0.005, 0.01, 
0.025, 0.05, 0.1 g/kg b.w., respectively, 
with CCl4 (i.p., 0.5 mL/kg b.w., 50 % 
CCl4 in olive oil) twice a week. 
After 28 days of treatment period, the 
animals were deprived of food overnight 
and anesthetized by exposing to diethyl 
ether and then sacrificed by cervical decapi-
tation. Blood was collected from jugular 
vein and serum was separated and used for 
liver marker assays. The liver tissue was 
dissected out, washed in ice-cold saline, 
and patted dry and weighed.  
Tissue sample was taken from hepatic 
lobes and was stored in 10 % formalin 
buffer solution for histopathological exami-
nation. From the remaining tissue, about 
100 mg tissue from liver was weighed and 
homogenized in chilled 0.1 M Tris-HCl 
buffer in Potter-Elvehjem Teflon homoge-
nizer. The homogenates were used for bio-
chemical investigation. 
 
Analytical procedure 
The serum was used for the estimation 
of hepatic marker enzymes namely serum 
ALT, AST (Reitman and Frankel, 1957), 
ALP (Anderch and Szczypinski, 1947) and 
GGT (Szasz, 1969). The liver tissue ho-
mogenates were used for the assay of SOD 
(Sun et al., 1988). 
 
Histopathological examination 
Formalin fixed samples were routinely 
embedded in paraffin blocks, sectioned at 
4 µm and stained with Haematoxylin and 
Eosin for microscopic examination. Liver 
sections were graded numerically to assess 
the degree of histological features in acute 
hepatic injury. Hepatocyte necrosis, fatty 
change, hyaline degeneration, ballooning 
degeneration, infiltration of Kupffer cells 
and lymphocytes were prominent in the his-
tological findings (Valeer, 2003). The liver 
pathology was scored as described by 
French et al., 2000 as follows: 
 Score 0 = no visible cell damage; 
 Score 1 = focal hepatocyte damage on 
less than 25 % of the tissue; 
 Score 2 = focal hepatocyte damage on 
25-50 % of the tissue; 
 Score 3 = extensive, but focal, hepato-
cyte lesions; 
 Score 4 = global hepatocyte necrosis. 
The morphology of any lesions ob-
served was classified and registered (Gray, 
1958). 
 
Statistical analysis 
The calculations and statistical analysis 
were carried out using the Statistical Pack-
age for Social Sciences (SPSS) for Win-
dows version 12.0 software. All data were 
represented as mean ± S.E.M. Data were 
subjected to one-way analysis of variance 
(ANOVA) followed by Tukey post hoc test. 
Statistical probability of P< 0.05 was con-
sidered to be significant. 
 
RESULTS 
Body weight and weight of liver 
Organ weight decrease is an indication 
of organ injury. Table 1 shows the effects 
of pantothenic acid on organ weight chang-
es observed in rats in response to CCl4 ad-
ministration. Body and liver weights dif-
fered significantly between the CCl4-treated 
group and the normal control group. How-
ever, pantothenic acid administration ame-
liorated the reduction in liver weight in 
CCl4-treated rats. 
 
Serum biochemical parameters 
ALT, AST and ALP are the important 
hepatic metabolic enzymes. When liver is 
damaged, these enzymes will be released 
from liver into serum. Thus, the activities of 
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these enzymes in serum can reflect the de-
gree of liver injury (Zhang et al., 2005). 
The experiments showed that CCl4 marked-
ly increased the activities of serum ALT, 
AST, ALP and GGT from rats of toxic con-
trol group as compared with the normal 
control group. But pantothenic acid effec-
tively reduced the activities of these en-
zymes. Treatment with pantothenic acid 
also reduced all measured serum biochemi-
cal activities towards normalization. There 
was no significant alteration in control rats 
treated solely with pantothenic acid (Table 2).  
Hepatic biochemical parameters 
SOD and GGT were measured as an in-
dex of antioxidant status of tissues. Signifi-
cantly lower activities of liver SOD was 
observed in CCl4-treated group as com-
pared to the normal control group (Table 2). 
There were significant increases in SOD 
activities in the pantothenic acid-treated 
groups compared to the CCl4-treated con-
trol group (p < 0.05). 
 
 
Table 1: Body weight and liver weight of acute CCl4 (50% CCl4/olive oil)-treated rats with or without 
pantothenic acid 
Groups Initial body 
weight (g) 
Final body 
weight (g) 
Weight gain 
(g) 
Liver weight (g) Relative liver 
weight 
(g liver/ 
100 g body)  
Control 207.14 ± 6.35 243.42 ± 5.48 36.28 ± 3.7 4.04 ± 0.14 1.66 ± 0.03 
Pantothenic acid  
(0.01 g/kg) 
227.85 ± 6.81 265.71 ± 8.05 37.86 ± 3.9 3.06 ± 0.05 1.15 ± 0.03 
Pantothenic acid  
(0.025 g/kg) 
221.57 ± 2.42 253.71 ± 8.08 32.14 ± 3.1 3.17 ± 0.06 1.25 ± 0.04 
CCl4 217.42 ± 5.03 219.23 ± 8.05*** 1.81 ± 0.5*** 5.18 ± 0.14*** 2.36 ± 0.05*** 
Pantothenic acid + 
CCl4 
0.005 g/kg + CCl4 
0.01 g/kg + CCl4 
0.025 g/kg + CCl4 
0.05 g/kg + CCl4 
0.1 g/kg + CCl4 
 
 
197.57 ± 5.62 
205.8 ± 5.42 
208.78 ± 5.11 
208.42 ± 4.41 
211.27 ± 6.32 
 
 
214.87 ± 8.83  
226.37 ± 5.85+ 
234.75 ± 3.34+++ 
235.01 ± 3.78+++ 
238.11 ± 4.78+++ 
 
 
17.3 ± 1.5 
20.57 ± 2.1+ 
25.97 ± 2.6+++ 
26.59 ± 2.6+++ 
26.84 ± 2.7+++ 
 
 
4.65 ± 0.12 
4.45 ± 0.08+ 
4.48 ± 0.13++ 
4.13 ± 0.11++ 
3.99 ± 0.16+++ 
 
 
2.16 ± 0.04  
1.97 ± 0.03+ 
1.91 ± 0.05++ 
1.76 ± 0.03+++ 
1.68 ± 0.04+++ 
Values are mean ± S.E.M. of 9 rats; *** p<0.001 significantly different from the control;  
+ p <0.05, ++ p<0.01, +++ p<0.001 significantly different from the group treated with CCl4 
 
Table 2: Effects of pantothenic acid on serum and liver biochemical indices in CCl4-induced hepato-
toxicity in rats 
Groups ALT (IU/L) AST (IU/L) ALP (IU/L) GGT (IU/L) SOD 
(IU/mg 
protein) 
Control 59.71 ± 3.44 191.6 ± 20.27 348.6 ± 18.43 2.83 ± 0.54 10.2 ± 2.7 
Pantothenic acid  
(0.01 g/kg) 
51.83 ± 3.32 97.0   ± 4.81 321 ± 38.35 1.83 ± 0.31 10.7 ± 2.4 
Pantothenic acid  
(0.025 g/kg) 
49.5 ± 3.77 141.0 ± 23.71 281 ± 26.62 2.16 ± 0.41 10.9 ± 2.6 
CCl4 1018.2 ± 41.6*** 923.0 ± 10.11*** 1013 ± 13*** 8.14 ± 1.56** 6.2 ± 1.7*** 
Pantothenic acid + 
CCl4 
0.005 g/kg + CCl4 
0.01 g/kg + CCl4 
0.025 g/kg + CCl4 
0.05 g/kg + CCl4 
0.1 g/kg + CCl4 
 
 
850.6 ± 72.04 
614.66 ± 128.8+ 
608.25 ± 122.8++ 
585.25 ± 122.8++ 
537± 81.75 +++ 
 
 
671.75 ±76.96 
594.2 ± 75.48++ 
447.5 ± 101.84+++ 
370.2 ± 53.14+++ 
319.66 ± 26.19+++ 
 
 
701.33 ± 61.33 
467.2 ± 48.91+++ 
402.5 ± 75.86+++ 
363.33 ± 24.13+++ 
338.12 ± 48.63+++ 
 
 
4.5 ± 1.38 
3.33 ± 0.98++ 
3.12 ± 1.12++ 
3.05 ± 0.86++ 
2.85 ± 0.55+++ 
 
 
7.8 ± 2.3 
8.2 ± 1.9+ 
8.5 ± 1.5++ 
8.7 ± 2.1++ 
9.1± 1.6+++ 
Values are mean ± S.E.M. of 9 rats; ** p<0.01, *** p<0.001 significantly different from the control;  
+ p<0.05, ++ p<0.01, +++ p<0.0001 significantly different from the group treated with CCl4 
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Table 3: Histological injury score of liver under different doses of pantothenic acid in rats treated with 
CCl4 (50 % CCl4/Olive oil) 
Index 
 
Groups 
Injury of scorea
Fatty degeneration Necrosis Cell swelling Inflammation Total scores 
Control 0 0 0 0 0 
Pantothenic acid  
(0.01 g/kg) 
0 0 0 0 0 
Pantothenic acid  
(0.025 g/kg) 
0 0 0 0 0 
CCl4 4 4 3 3 14 
Pantothenic acid + CCl4 
0.005 g/kg + CCl4 
0.01 g/kg + CCl4 
0.025 g/kg + CCl4 
0.05 g/kg + CCl4 
0.1 g/kg + CCl4 
 
4 
4 
4 
3 
3 
 
4 
4 
4 
3 
2 
 
3 
3 
3 
1 
1 
 
3 
2 
2 
1 
1 
 
14 
13 
13 
8 
7 
a Livers were scored for hepatic injury via light microscopy with score 0 = no visible cell damage; score 
1 = focal hepatocyte damage on less than 25 % of the tissue; score 2 = focal hepatocyte damage on 
25-50 % of the tissue; score 3 = extensive, but focal, hepatocyte lesions; score 4 = global hepatocyte 
necrosis 
 
 
Histopathological findings 
The severity of the liver morphological 
changes and fibrosis induced by CCl4 
treatment were scored and summarized. 
Our results showed that administration of 
pantothenic acid greatly improved liver 
morphological changes, fibrosis and necro-
sis. The average severity scores of panto-
thenic acid-treated rats were markedly re-
duced in a dose-dependent manner (Table 
3). The livers of the rats from control group 
had no noticeable histological changes 
(Figure 1A). Severe histopathological chan-
ges were consistently observed in livers of 
all the rats from CCl4-treated group. The 
predominant lesions were extensive hy-
dropic degeneration, necrosis and infiltra-
tion of inflammatory cells (Figure 1D). 
These changes were seen in almost all lob-
ules, and were more pronounced in centri-
lobular and intermediate areas. Most 
hepatocytes in the degenerative and necro-
tic regions had pykneotic nuclei, and were 
so swollen that several cells had ruptured. 
In addition, some hepatocytes in the peri-
portal regions had moderate to severe cyto-
plasmic vacuolation, indicating fatty 
change. However, the livers of all animals 
showed no cirrhotic changes with the re-
generative nodules or fibrous bands extend-
ing to parenchyma. The histological ap-
pearance of the pantothenic acid group was 
quite similar to that of the control group 
(Figures 1B and 1C). Administration of 
pantothenic acid ameliorated or reversed 
the changes induced by CCl4 in part. The 
lesions in the liver of rats that received 
CCl4+ pantothenic acid were conspicuously 
less than those in the rats that received CCl4 
only. The livers from the rats in this group 
showed occasional apoptotic and dysplastic 
hepatocytes, most of which were not ab-
normal, but no extensive hydropic degener-
ation and necrotic changes were seen in any 
of the livers. Moreover, the architecture of 
lobules was not disrupted and the hepato-
cytes mostly had normal appearance (Fig-
ures 1E-1I). However, only few lobules of 
livers showed a focus of degenerative cells, 
most of which had normal nuclear appear-
ance and mild cytoplasmic degeneration. 
Morphological findings in all groups of this 
study were consistent with observations of 
serum enzymes of AST, ALT and ALP val-
ues. 
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Figure 1A 
 
 
Figure 1B 
 
 
Figure 1C 
 
 
Figure 1D 
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Figure 1G 
 
 
Figure 1H 
 
Figure 1I 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
CCl4 is a well-known hepatotoxin that is 
widely used to induce toxic liver injury in a 
range of laboratory animals. CCl4-induced 
hepatotoxicity is believed to involve two 
phases. The initial phase involves the me-
tabolism of CCl4 by cytochrome P450 to the 
trichloromethyl radicals (CCl3● and/or 
CCl3OO●), which lead to membrane lipid 
peroxidation and finally to cell necrosis 
(Basu, 2003; Manibusan et al., 2007). The 
second phase of CCl4-induced hepatotoxici-
ty involves the activation of Kupffer cells, 
which is accompanied by the production of 
proinflammatory mediators (Planaguma et 
al., 2005). Several microarray studies have 
been reported describing gene expression 
changes caused by acute CCl4 toxicity 
(Harries et al., 2001), although the signifi-
cance of these changes has not been fully 
understood. 
In the present study, the capability of 
pantothenic acid to protect against CCl4-
induced hepatotoxicity and oxidative stress 
was investigated. Results indicated that 
pantothenic acid was able to suppress the 
hepatotoxicity of CCl4 and the hepatopro-
tective effect. Levels of some important  
biochemical parameters in serum are used 
as diagnostic markers of hepatic injury. One 
of the most sensitive and dramatic indica-
tors of hepatocyte injury is the release of 
intracellular enzymes, such as transaminas-
es and serum alkaline phosphatase in the 
circulation after CCl4 administration. The 
elevated activities of these enzymes are in-
dicative of cellular leakage and loss of the 
functional integrity of the cell membranes 
in liver which is always associated with 
Figure 1: Effect of pantothenic acid on CCl4-
induced liver damage in Wistar rats. (A) liver 
of normal untreated control showing intact 
basic liver structures like central vein (CV) 
and hepatocytes (arrow), (B, C) liver in group 
II (B) and group III (C), showing normal struc-
ture and hepatocytes (arrow), separated line 
is artifact, (D) liver of group IV, showing 
hepatocytes necrosis (arrow head), fatty de-
generation (arrow) and infiltration of inflam-
matory cells, (E-I) liver in group V (E), VI (F), 
VII (G), VIII (H) and IX (I), show that hepato-
cyte necrosis (arrow), fatty degeneration (ar-
row head) and infiltration of inflammatory 
cells (H&E *640). 
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hepatonecrosis (Naik and Panda, 2008; Ra-
jesh and Latha, 2004). With the treatment 
of pantothenic acid, the levels of these 
marker enzymes were near normal or only 
slightly elevated, indicating protection 
against liver damage. ALP activity is relat-
ed to the functioning of hepatocytes. Sup-
pression of increased ALP activity suggests 
the stability of biliary dysfunction in rat liv-
er during chronic hepatic injury with CCl4 
(Mukherjee, 2002). ALP is a membrane as-
sociated enzyme and an increased activity 
of ALP is an indication of liver damage 
(Giannini et al., 2005). GGT is a microso-
mal enzyme present in hepatocytes and its 
primary role is to metabolize extracellular 
glutathione allowing for precursor amino 
acids to be assimilated and reutilized for 
intracellular glutathione synthesis. An in-
crease in serum GGT is a defense mecha-
nism reflecting the induction of cellular 
GGT, when there is oxidative stress (Lee et 
al., 2004). Diminution of total protein and 
albumin induced by CCl4 is a further indi-
cation of liver damage (Navarro and Senior, 
2006). Stimulation of protein synthesis has 
been advanced as a contributory hepatopro-
tective mechanism which accelerates the 
regeneration process and the production of 
liver cells (Rip et al., 1985; Tadeusz et al., 
2001). 
SOD and CAT are two important enzy-
matic antioxidants that act against toxic ox-
ygen free radicals such as superoxide (O2¯) 
and hydroxyl ions (OH¯) in biological sys-
tems (Burton et al., 1983). It is reported that 
antioxidant enzymes, such as SOD, CAT 
and the glutathione system, have been 
known to play important roles in alleviating 
oxidative damage, since they are involved 
in the direct elimination of reactive oxygen 
species (Fang et al., 2002; Ravid et al., 
1999). CAT prevents oxidative hazards by 
catalyzing the formation of H2O and O2 
from H2O2 (Kumar and Kuttan, 2003). In 
our present study we observed a decrease in 
the SOD activities of the liver tissues on 
CCl4 administration. Pantothenic acid ad-
ministration to CCl4-treated rats significant-
ly increased the SOD activities. Our find-
ings are in line with the observations by 
other authors on radioprotective and antiox-
idative effects of pantothenic acid and pan-
tothenol (Nagiel-Ostaszewski and Lau-
Cam, 1990; Utno, 1991; Kumerova et al., 
1991, 1992). It is reported that pantothenic 
acid alleviated the ultraviolet-induced de-
crease of glutathione content, diminished 
lipid peroxidation, and partly protected the 
cells against apoptosis produced by ultravi-
olet irradiation (Slyshenkov et al., 2001). In 
all these experiments pantothenic acid pre-
sumably helped to remove ROS and pro-
tects against apoptosis. Thus, pantothenic 
acid and some of its derivatives may be a 
valuable tool in treatment of impairments 
related to oxidative stress. It is suggested 
that an increase of total glutathione ob-
served after treatment of the cells or whole 
animals with pantothenic acid or panto-
thenol might arise from reductive breakage 
of disulfide bonds in protein-bound gluta-
thione and liberation of glutathione (Sly-
shenkov et al., 2001, 1998). It is reported 
that pantothenic acid and its related com-
pounds protect the plasma membrane of 
Ehrlich ascites tumor cells against the dam-
age by oxygen free radicals due to increas-
ing cellular level of CoA. The latter com-
pound may act by diminishing propagation 
of lipid peroxidation and promoting repair 
mechanisms, mainly the synthesis of phos-
pholipids (Slyshenkov et al., 1996). 
The histological results reported in the 
current study confirmed the biochemical 
results and indicated that CCl4 induced se-
vere histological changes in the hepatic tis-
sues. Similar histological changes in the 
liver have been documented previously 
(Bilgin et al., 2011; Çetin et al., 2011). The 
acute hepatotoxic effects induced by CCl4 
administration were confirmed histopatho-
logically, revealing extensive hepatocellular 
degeneration and necrosis, fatty changes, 
inflammatory cell infiltration, congestion, 
and sinusoidal dilatation. We also observed 
thickening portal tract with cellular debris 
and periportal fibrosis. The hepatocytes 
showed vacuolar degeneration and nuclear 
pleomorphism. In contrast, our histological 
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results showed that treatment with panto-
thenic acid effectively protected rats against 
CCl4-induced hepatic toxicity. Treatment 
with pantothenic acid prevented the necro-
sis and the other histopathological changes 
induced by CCl4 treatment. 
In summary, this study demonstrates 
that pantothenic acid had a protective effect 
against CCl4-induced acute hepatic damage 
in rats. The hepatoprotective effect of pan-
tothenic acid is likely due to its ability to 
the inflammatory responses, in combination 
with the ability to scavenge free radicals. 
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